Woodline Partners LP - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,566,218
+430.5%
851,489
+658.8%
0.21%
+428.2%
Q2 2023$3,311,376
+43.3%
112,212
+11.9%
0.04%
+25.8%
Q1 2023$2,311,165
-83.0%
100,311
-77.4%
0.03%
-83.8%
Q3 2022$13,634,000
+156.0%
444,256
+145.5%
0.19%
+132.9%
Q2 2022$5,326,000
-35.5%
180,972
-29.5%
0.08%
-38.8%
Q1 2022$8,257,000
+253.0%
256,678
+389.3%
0.13%
+294.1%
Q4 2021$2,339,00052,4540.03%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders